Ceftron 500 mg/vial (IM Injection)
500 mg vial: ৳ 200.00
Medicine Details
Category | Details |
---|---|
Generic | Ceftriaxone sodium |
Company | Square pharmaceuticals plc |
Also available as |
Indications
- Lower respiratory tract infections
- Acute Bacterial Otitis Media
- Skin and skin structure infections
- Urinary tract infections
- Gonorrhea
- Bacterial Septicemia
- Bone and joint infections
- Meningitis
- Prevention of postoperative infections
- Perioperative prophylaxis of infections associated with surgery
Pharmacology
- 3rd generation broad-spectrum parenteral cephalosporin antibiotic
- Bactericidal activity against a wide range of Gram-positive and Gram-negative organisms
- Interferes with the synthesis of the bacterial cell wall
- High degree of stability in the presence of beta lactamases
- Long plasma elimination half-life of about 6 to 9 hours
- Not metabolized in the body
- Excretion of 40-65% unchanged in the urine
- Highly protein bound (95%)
Dosage
- Usual dose for adults is 1 to 2 gm by intravenous or intramuscular administration once a day
- Maximum dose for adults is 4 gm/day
- Usual dose for infants and children (01 month or older) is 50 to 75 mg/kg intravenous or intramuscular administration once a day
- Maximum dose for infants and children is 2 gm/day
- Uncomplicated gonococcal infections: 250 mg IM as a single dose
- Surgical prophylaxis: 1 g IV as a single dose 30 to 120 minutes before surgery
- Duration of therapy: Usually 4 to 14 days
Administration
- Preparation of Solutions for Intramuscular / Intravenous Injections
- Different dissolution requirements for intramuscular and intravenous injections
- Injection should be administered over specific time periods and concentrations
- Patient tolerance test recommended before starting treatment
Interaction
- No reported drug interactions
Contraindications
- Not to be given to patients with a history of hypersensitivity to cephalosporin antibiotics
Side Effects
- Gastro-intestinal effects including diarrhea, nausea, and vomiting
- Cutaneous reactions including rash, pruritus, urticaria, edema, and erythema multiforme
- Hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia, and neutropenia
- Hepatic reactions including elevations of SGOT or SGPT, bilirubinemia
- CNS reactions including nervousness, confusion, sleep disturbances, headache, convulsion, hypertonia, and dizziness
- Rare occurrence of local phlebitis following intravenous administration
Pregnancy & Lactation
- Safety in human pregnancy not established
- Caution advised when administered to lactating mothers
Precautions & Warnings
- Potential for anaphylactic shock
- Rare cases of gallbladder sludge detected
- Blood picture should be checked at regular intervals during prolonged treatment
Use in Special Populations
- Not to be given to neonates if premature and newborn (up to 28 days of age)
Overdose Effects
- No specific antidote
- Treatment should be symptomatic
Therapeutic Class
- Third generation Cephalosporins
Storage Conditions
- Vial store in a cool, dry place (below 30°C)
- Store away from light & moisture
- Keep out of the reach of children
Related Brands
- Ceftron 250 mg/vial (IV Injection) - square-pharmaceuticals-plc
- Ceftron 500 mg/vial (IV Injection) - square-pharmaceuticals-plc
- Ceftron 1 gm/vial (IV Injection) - square-pharmaceuticals-plc
- Ceftron 2 gm/vial (IV Injection) - square-pharmaceuticals-plc
- Dicephin 250 mg/vial (IM Injection) - drug-international-ltd